The Zhitong Finance App learned that on Monday, an American judge rejected Novo Nordisk (NVO.US)'s request to ban LLY.US (LLY.US) from continuing to advertise diet pills. The Danish pharmaceutical company believes the advertisement in question is false and misleading, and the market covered by the advertisement has annual sales of tens of billions of dollars.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.